80_FR_8123 80 FR 8093 - The Tobacco Products Scientific Advisory Committee; Notice of Meeting

80 FR 8093 - The Tobacco Products Scientific Advisory Committee; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 30 (February 13, 2015)

Page Range8093-8094
FR Document2015-03000

Federal Register, Volume 80 Issue 30 (Friday, February 13, 2015)
[Federal Register Volume 80, Number 30 (Friday, February 13, 2015)]
[Notices]
[Pages 8093-8094]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-03000]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-0001]


The Tobacco Products Scientific Advisory Committee; Notice of 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: The Tobacco Products Scientific Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the Agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 9, 2015, from 8:30 
a.m. to 5 p.m. and April 10, 2015, from 8 a.m. to 5 p.m.
    Location: FDA White Oak, 10903 New Hampshire Ave., Building 31 
Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993-
0002. Answers to commonly asked questions including information 
regarding special accommodations due to a disability, visitor parking, 
and transportation may be accessed at: http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm.
    Contact Person: Caryn Cohen, Office of Science, Center for Tobacco 
Products, Food and Drug Administration, Document Control Center, Bldg. 
71, Rm. G335, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 
1-877-287-1373, email: TPSAC@fda.hhs.gov. A notice in the Federal 
Register about last minute modifications that impact a previously 
announced advisory committee meeting cannot always be published quickly 
enough to provide timely notice. Therefore, you should always check the 
Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm 
and scroll down to the appropriate advisory committee meeting link, or 
call the advisory committee information line to learn about possible 
modifications before coming to the meeting.
    Agenda: On April 9 and 10, 2015, the Committee will discuss 
modified risk tobacco product applications submitted by Swedish Match 
North America Inc. for 10 tobacco products:
     MR0000020: General Loose, smokeless tobacco, loose snus, 
1.59 oz (45g), cardboard can (SKU 4852);
     MR0000021: General Dry Mint Portion Original Mini, 
smokeless tobacco, snus portions, 0.21 oz (6g), 20 0.3g portions, 
plastic can (SKU 4800);
     MR0000022: General Portion Original Large, smokeless 
tobacco, snus portions, 0.9 oz (24g), 24 1g portions, plastic can (SKU 
4880);
     MR0000023: General Classic Blend Portion White Large, 
smokeless tobacco, snus portions, 0.48 oz (13.5g), 15 0.9g portions, 
plastic can (SKU 4877);
     MR0000024: General Classic Blend Portion White Large, 
smokeless tobacco, snus portions, 0.38 oz (10.8g), 12 0.9g portions, 
plastic can (SKU 4878);
     MR0000025: General Mint Portion White Large, smokeless 
tobacco, snus portions, 0.9 oz (24g), 24 1g portions, plastic can (SKU 
4352);
     MR0000026: General Nordic Mint Portion White Large, 
smokeless tobacco, snus portions, 0.48 oz (13.5g), 15 0.9g portions, 
plastic can (SKU 4876);
     MR0000027: General Nordic Mint Portion White Large, 
smokeless tobacco, snus portions, 0.38 oz (10.8g), 12 0.9g portions, 
plastic can (SKU 4875);
     MR0000028: General Portion White Large, smokeless tobacco, 
snus portions, 0.9 oz (24g), 24 1g portions, plastic can (SKU 4881); 
and
     MR0000029: General Wintergreen Portion White Large, 
smokeless tobacco, snus portions, 0.9 oz (24g), 24 1g portions, plastic 
can (SKU 4882).
    FDA intends to make background material available to the public no 
later than 2 business days before the meeting. If FDA is unable to post 
the background material on its Web site prior to the meeting, the 
background material will be made publicly available at the location of 
the advisory committee meeting, and the background material will be 
posted on FDA's Web site after

[[Page 8094]]

the meeting. Background material is available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate 
advisory committee meeting link.
    Procedure: On April 9, 2015, from 8:30 a.m. to 4 p.m. and on April 
10, 2015, from 8 a.m. to 5 p.m., the meeting is open to the public. 
Interested persons may present data, information, or views, orally or 
in writing, on issues pending before the committee. Written submissions 
may be made to the contact person on or before March 20, 2015. Oral 
presentations from the public will be scheduled between approximately 
11 a.m. and 12 p.m. on April 10, 2015. Those individuals interested in 
making formal oral presentations should notify the contact person and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation on or before March 12, 2015. Time allotted for 
each presentation may be limited. If the number of registrants 
requesting to speak is greater than can be reasonably accommodated 
during the scheduled open public hearing session, FDA may conduct a 
lottery to determine the speakers for the scheduled open public hearing 
session. The contact person will notify interested persons regarding 
their request to speak by March 13, 2015.
    Closed Committee Deliberations: On April 9, 2015, between 4 p.m. 
and 5 p.m., the meeting will be closed to permit discussion and review 
of trade secret and/or confidential commercial information (see 5 
U.S.C. 552b(c)(3) and (c)(4)). This portion of the meeting will be 
closed because the Committee will be discussing trade secret and/or 
confidential data provided by Swedish Match North America Inc.
    Persons attending FDA's advisory committee meetings are advised 
that the Agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Caryn Cohen at least 
7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee 
meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures 
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 9, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-03000 Filed 2-12-15; 8:45 am]
BILLING CODE 4164-01-P



                                                                            Federal Register / Vol. 80, No. 30 / Friday, February 13, 2015 / Notices                                           8093

                                              related to the approval process for these               Freedom of Information request. Written               287–1373, email: TPSAC@fda.hhs.gov.
                                              products that can be accomplished                       requests are to be sent to the Division               A notice in the Federal Register about
                                              under the Agency’s existing statutory                   of Freedom of Information (ELEM–                      last minute modifications that impact a
                                              authority. FDA will consider comments                   1029), Food and Drug Administration,                  previously announced advisory
                                              received at this meeting as it moves                    12420 Parklawn Dr., Element Bldg.,                    committee meeting cannot always be
                                              forward with this process.                              Rockville, MD 20857. Additionally,                    published quickly enough to provide
                                                 FDA has already opened public                        FDA will be recording the meeting via                 timely notice. Therefore, you should
                                              docket FDA Docket No. FDA–2014–N–                       Adobe Connect on March 16, 2015.                      always check the Agency’s Web site at
                                              1050 to receive comments on the issue                   Once the recording has been made 508                  http://www.fda.gov/
                                              (79 FR 53431, September 9, 2014).                       compliant, it will be accessible at FDA’s             AdvisoryCommittees/default.htm and
                                              Although you can comment on this                        CVM Web site at http://www.fda.gov/                   scroll down to the appropriate advisory
                                              document at any time, to ensure that the                ForIndustry/UserFees/                                 committee meeting link, or call the
                                              Agency considers your comment before                    AnimalDrugUserFeeActADUFA/                            advisory committee information line to
                                              finalizing work on the exploration                      ucm042891.htm.                                        learn about possible modifications
                                              process described in this document,                                                                           before coming to the meeting.
                                                                                                        Dated: February 10, 2015.
                                              submit either electronic or written                                                                              Agenda: On April 9 and 10, 2015, the
                                              comments by March 31, 2016.                             Leslie Kux,
                                                                                                                                                            Committee will discuss modified risk
                                                                                                      Associate Commissioner for Policy.
                                              II. Participation in a Public Meeting                                                                         tobacco product applications submitted
                                                                                                      [FR Doc. 2015–03002 Filed 2–12–15; 8:45 am]           by Swedish Match North America Inc.
                                                 While oral presentations from specific               BILLING CODE 4164–01–P                                for 10 tobacco products:
                                              individuals and organizations may be                                                                             • MR0000020: General Loose,
                                              limited due to time constraints during                                                                        smokeless tobacco, loose snus, 1.59 oz
                                              the public meeting, stakeholders may                    DEPARTMENT OF HEALTH AND                              (45g), cardboard can (SKU 4852);
                                              submit electronic or written comments                   HUMAN SERVICES                                           • MR0000021: General Dry Mint
                                              discussing any issues of concern to the                                                                       Portion Original Mini, smokeless
                                              administration record (the docket). All                 Food and Drug Administration
                                                                                                                                                            tobacco, snus portions, 0.21 oz (6g), 20
                                              relevant data and documentation should                  [Docket No. FDA–2015–N–0001]                          0.3g portions, plastic can (SKU 4800);
                                              be submitted with the comments to                                                                                • MR0000022: General Portion
                                              Docket No. FDA–2014–N–1050. Submit                      The Tobacco Products Scientific                       Original Large, smokeless tobacco, snus
                                              electronic comments to http://                          Advisory Committee; Notice of Meeting                 portions, 0.9 oz (24g), 24 1g portions,
                                              www.regulations.gov. Submit written                                                                           plastic can (SKU 4880);
                                              comments to the Division of Dockets                     AGENCY:    Food and Drug Administration,                 • MR0000023: General Classic Blend
                                              Management (HFA–305), Food and Drug                     HHS.                                                  Portion White Large, smokeless tobacco,
                                              Administration, 5630 Fishers Lane, Rm.                  ACTION:   Notice.                                     snus portions, 0.48 oz (13.5g), 15 0.9g
                                              1061, Rockville, MD 20852. It is only                                                                         portions, plastic can (SKU 4877);
                                              necessary to send one set of comments.                    This notice announces a forthcoming                    • MR0000024: General Classic Blend
                                              Identify comments with the docket                       meeting of a public advisory committee                Portion White Large, smokeless tobacco,
                                              number FDA–2014–N–1050. Received                        of the Food and Drug Administration                   snus portions, 0.38 oz (10.8g), 12 0.9g
                                              comments may be seen in the Division                    (FDA). At least one portion of the                    portions, plastic can (SKU 4878);
                                              of Dockets Management between 9 a.m.                    meeting will be closed to the public.                    • MR0000025: General Mint Portion
                                              and 4 p.m., Monday through Friday, and                    Name of Committee: The Tobacco                      White Large, smokeless tobacco, snus
                                              will be posted to the docket at http://                 Products Scientific Advisory                          portions, 0.9 oz (24g), 24 1g portions,
                                              www.regulations.gov.                                    Committee.                                            plastic can (SKU 4352);
                                              III. Comments, Transcripts, and
                                                                                                        General Function of the Committee:                     • MR0000026: General Nordic Mint
                                                                                                      To provide advice and                                 Portion White Large, smokeless tobacco,
                                              Recorded Video                                          recommendations to the Agency on                      snus portions, 0.48 oz (13.5g), 15 0.9g
                                                 Information and data submitted                       FDA’s regulatory issues.                              portions, plastic can (SKU 4876);
                                              voluntarily to FDA during the public                      Date and Time: The meeting will be                     • MR0000027: General Nordic Mint
                                              meeting will become part of the                         held on April 9, 2015, from 8:30 a.m. to              Portion White Large, smokeless tobacco,
                                              administrative record and will be                       5 p.m. and April 10, 2015, from 8 a.m.                snus portions, 0.38 oz (10.8g), 12 0.9g
                                              accessible to the public at http://                     to 5 p.m.                                             portions, plastic can (SKU 4875);
                                              www.regulations.gov. The transcript of                    Location: FDA White Oak, 10903 New                     • MR0000028: General Portion White
                                              the proceedings from the public meeting                 Hampshire Ave., Building 31                           Large, smokeless tobacco, snus portions,
                                              will become part of the administrative                  Conference Center, the Great Room (Rm.                0.9 oz (24g), 24 1g portions, plastic can
                                              record. Please be advised that as soon as               1503), Silver Spring, MD 20993–0002.                  (SKU 4881); and
                                              a transcript is available, it will be                   Answers to commonly asked questions                      • MR0000029: General Wintergreen
                                              accessible at http://                                   including information regarding special               Portion White Large, smokeless tobacco,
                                              www.regulations.gov, Docket No. FDA–                    accommodations due to a disability,                   snus portions, 0.9 oz (24g), 24 1g
                                              2014–N–1050, and at FDA’s CVM Web                       visitor parking, and transportation may               portions, plastic can (SKU 4882).
                                              site at: http://www.fda.gov/ForIndustry/                be accessed at: http://www.fda.gov/                      FDA intends to make background
                                              UserFees/                                               AdvisoryCommittees/                                   material available to the public no later
                                              AnimalDrugUserFeeActADUFA/                              AboutAdvisoryCommittees/                              than 2 business days before the meeting.
tkelley on DSK3SPTVN1PROD with NOTICES




                                              ucm042891.htm. It may also be viewed                    ucm408555.htm.                                        If FDA is unable to post the background
                                              at the Division of Dockets Management                     Contact Person: Caryn Cohen, Office                 material on its Web site prior to the
                                              (HFA–305), Food and Drug                                of Science, Center for Tobacco Products,              meeting, the background material will
                                              Administration, 5630 Fishers Lane, Rm.                  Food and Drug Administration,                         be made publicly available at the
                                              1061, Rockville, MD 20852. A transcript                 Document Control Center, Bldg. 71, Rm.                location of the advisory committee
                                              will also be available in either hardcopy               G335, 10903 New Hampshire Ave.,                       meeting, and the background material
                                              or on CD–ROM, after submission of a                     Silver Spring, MD 20993–0002, 1–877–                  will be posted on FDA’s Web site after


                                         VerDate Sep<11>2014   21:56 Feb 12, 2015   Jkt 235001   PO 00000   Frm 00039   Fmt 4703   Sfmt 4703   E:\FR\FM\13FEN1.SGM   13FEN1


                                              8094                          Federal Register / Vol. 80, No. 30 / Friday, February 13, 2015 / Notices

                                              the meeting. Background material is                     public conduct during advisory                        accomplishing the NIH mission. The
                                              available at http://www.fda.gov/                        committee meetings.                                   Selected Alternative will provide a
                                              AdvisoryCommittees/Calendar/                              Notice of this meeting is given under               guide for the reasoned and orderly
                                              default.htm. Scroll down to the                         the Federal Advisory Committee Act (5                 development of the NIH campus, one
                                              appropriate advisory committee meeting                  U.S.C. app. 2).                                       that values and builds on existing
                                              link.                                                     Dated: February 9, 2015.                            resources, corrects current deficiencies
                                                 Procedure: On April 9, 2015, from                    Leslie Kux,                                           and meets changing needs through new
                                              8:30 a.m. to 4 p.m. and on April 10,                                                                          construction or renovation. The plan
                                                                                                      Associate Commissioner for Policy.
                                              2015, from 8 a.m. to 5 p.m., the meeting                                                                      sets forth implementation priorities and
                                                                                                      [FR Doc. 2015–03000 Filed 2–12–15; 8:45 am]
                                              is open to the public. Interested persons                                                                     a logical sequencing of planned
                                              may present data, information, or views,                BILLING CODE 4164–01–P
                                                                                                                                                            development.
                                              orally or in writing, on issues pending                                                                          The Selected Alternative is for a long-
                                              before the committee. Written                                                                                 range physical Master Plan for NIH.
                                              submissions may be made to the contact                  DEPARTMENT OF HEALTH AND                              This alternative covers a 20-year
                                              person on or before March 20, 2015.                     HUMAN SERVICES                                        planning period, with reviews every 5
                                              Oral presentations from the public will                 National Institutes of Health                         years to ensure that the plan continues
                                              be scheduled between approximately 11                                                                         to address issues affecting the campus.
                                              a.m. and 12 p.m. on April 10, 2015.                     Bethesda Campus Master Plan Record                    The alternative addresses the future
                                              Those individuals interested in making                  of Decision                                           development of the NIH site, including
                                              formal oral presentations should notify                                                                       placement of future construction;
                                              the contact person and submit a brief                   SUMMARY:    The Department of Health and              vehicular and pedestrian circulation on
                                              statement of the general nature of the                  Human Services, the National Institutes               and off-campus; parking within the
                                              evidence or arguments they wish to                      of Health (NIH), has decided, after                   property boundaries; open space in and
                                              present, the names and addresses of                     completion of a Final Environmental                   around the campus; required setbacks;
                                              proposed participants, and an                           Impact Statement (FEIS) and a thorough                historic properties; natural and scenic
                                              indication of the approximate time                      consideration of the public comments                  resources; noise; and lighting. This
                                              requested to make their presentation on                 on the Draft EIS, to implement the                    alternative accounts for potential growth
                                              or before March 12, 2015. Time allotted                 Proposed Action, referred to as the                   in NIH personnel, and consequent
                                              for each presentation may be limited. If                Proposed Action in the Final EIS. This                construction of space over the planning
                                              the number of registrants requesting to                 action is for a long-range physical                   period. Future construction on the site
                                              speak is greater than can be reasonably                 Master Plan for National Institutes of                could include such facilities as new
                                              accommodated during the scheduled                       Health Bethesda Campus (NIH) located                  animal holding, research laboratories,
                                              open public hearing session, FDA may                    in Bethesda, Maryland. This alternative               and support facilities.
                                              conduct a lottery to determine the                      accounts for potential growth in NIH                     NIH will continue to develop the
                                              speakers for the scheduled open public                  personnel, new construction, additions,               Bethesda campus to accommodate NIH’s
                                              hearing session. The contact person will                renovations, demolitions, and upgrades                research needs and required
                                              notify interested persons regarding their               in site utilities.                                    programmatic needs consistent with the
                                              request to speak by March 13, 2015.                       Responsible Official: Daniel G.                     commitment to maintain the ‘‘campus’’
                                                 Closed Committee Deliberations: On                   Wheeland, Director, Office of Research                character of the site. The Selected
                                              April 9, 2015, between 4 p.m. and 5                     Facilities (ORF) Development and                      Alternative advances this objective by
                                              p.m., the meeting will be closed to                     Operations, NIH.                                      programming and locating future NIH
                                              permit discussion and review of trade                   FOR FURTHER INFORMATION CONTACT:                      growth so that new development would
                                              secret and/or confidential commercial                   Valerie Nottingham, Deputy Director,                  tie into the existing utility services and
                                              information (see 5 U.S.C. 552b(c)(3) and                DEP, ORF, NIH, Building 13, Room                      utilities are available to support growth,
                                              (c)(4)). This portion of the meeting will               2S11, 9000 Rockville Pike, Bethesda,                  and establishing development
                                              be closed because the Committee will be                 MD 20892, Phone 301–496–7775,                         guidelines for future changes to the site
                                              discussing trade secret and/or                          nihnepa@mail.nih.gov.                                 that ensure that as the campus grows
                                              confidential data provided by Swedish                   SUPPLEMENTARY INFORMATION:                            new development would be responsive
                                              Match North America Inc.                                                                                      to the context of adjacent neighborhoods
                                                 Persons attending FDA’s advisory                     Decision                                              or developments. Under the Selected
                                              committee meetings are advised that the                   After careful review of the                         Alternative, the total NIH population on
                                              Agency is not responsible for providing                 environmental consequences in the                     the campus is anticipated to grow in the
                                              access to electrical outlets.                           Final Environmental Impact Statement                  next twenty years to a total of
                                                 FDA welcomes the attendance of the                   for the Master Plan, National Institutes              approximately 23,594, which is an
                                              public at its advisory committee                        of Health Bethesda Campus, and                        increase of approximately 3,000
                                              meetings and will make every effort to                  consideration of public comment                       employees. The primary growth at the
                                              accommodate persons with physical                       throughout the NEPA process, the NIH                  campus would be in intramural research
                                              disabilities or special needs. If you                   has decided to implement the Proposed                 personnel and the administrative and
                                              require special accommodations due to                   Action described below as the Selected                facility staff to support them. The
                                              a disability, please contact Caryn Cohen                Alternative.                                          majority, if not all, of the employees
                                              at least 7 days in advance of the                                                                             would be coming from off-site facilities
                                              meeting.                                                Selected Alternative
                                                                                                                                                            and are already employees, or
tkelley on DSK3SPTVN1PROD with NOTICES




                                                 FDA is committed to the orderly                         The Selected Alternative is intended               contractors, of NIH.
                                              conduct of its advisory committee                       to be a strategic tool for the efficient
                                              meetings. Please visit our Web site at                  allocation of campus resources, the                   Alternatives Considered
                                              http://www.fda.gov/                                     orderly accommodation of future                          The Proposed Action Alternative, the
                                              AdvisoryCommittees/                                     growth, and the creation of an                        Redevelopment Alternative and No
                                              AboutAdvisoryCommittees/                                environment that is both functionally                 Action Alternative were the three
                                              ucm111462.htm for procedures on                         and aesthetically conducive to                        alternatives analyzed in the Final EIS.


                                         VerDate Sep<11>2014   21:56 Feb 12, 2015   Jkt 235001   PO 00000   Frm 00040   Fmt 4703   Sfmt 4703   E:\FR\FM\13FEN1.SGM   13FEN1



Document Created: 2015-12-18 13:18:23
Document Modified: 2015-12-18 13:18:23
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
FR Citation80 FR 8093 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR